Only logged in customers who have purchased this product may leave a review.
Sale!
Forbidden Drugs (Paperback) | Released: 01 Sep 2009
By: Philip Robson (Author) Publisher: OUP Oxford33.00% Off Original price was: 1,640.00$.1,099.00$Current price is: 1,099.00$.
You save 541.00$
Recreational drug use is a world-wide phenomenon. Despite the best efforts of governments, the public fascination with drugs shows no signs of abating. With media accounts of illegal drug use often verging on the hysterical, this book provides a refreshingly balanced and honest account of drug use throughout the world,... Read More
In stock
Ships within 1-2 Business Days
100% Orginal Books
Easy Replacement
Certified product
Secure Checkout
On time delivery
Author:
Philip Robson
Publisher Name:
OUP Oxford
Language:
English
Binding:
(Paperback)
About The Book
Recreational drug use is a world-wide phenomenon. Despite the best efforts of governments, the public fascination with drugs shows no signs of abating. With media accounts of illegal drug use often verging on the hysterical, this book provides a refreshingly balanced and honest account of drug use throughout the world, one based on scientific fact, and not on dogma. The book examines all the drugs currently used throughout the world, looking at their effects and side-effects. Why do peple use drugs? Why do they become addicted? What are the lessons to be learned from making drugs illegal? Updated for the third edition with chapters rewritten to take account of scientific, epidemiological and political developments since the second edition, and with a new section on the present and future US drug policy from high-profile contributors, the book provides a much needed rational approach to the problem of drug use.About the Author: Dr Philip Robson (MBBS, MRCP, FRCPsych) gained experience in hospital medicine, clinical pharmacology and drug development before training as a psychiatrist. He has worked in drug dependency units in Melbourne and London and developed a regional service for drug users in Oxfordshire. Since 2000 he has worked with GW Pharmaceuticals plc in exploring the therapeutic potential of cannabis-based medicines.
Reviews
There are no reviews yet.